Cannabis
First to Market Equine Cannabis Brand Launches in Canada
CannaHorse today announced it will launch the world’s first ever legal cannabis brand dedicated to horse health, providing a plant-based solution to traditional pharmaceuticals.
Created for horse people, by horse people, CannaHorse will launch four product lines, created from specific formulations of cannabis using key cannabinoids and terpenes to treat ailments common in equine medicine. Product lines will be targeted to address concerns like pain and inflammation, anxiety/calming, exercise and surgical recovery, and overall wellness. Discussions are already well underway with equine competition regulators to provide the data necessary for cannabis to be viewed as equine medicine.
The brand has access to a large number of horses and two testing facilities exclusively for performance tests and clinical trials. The horses are of varying ages and breeds and are used for both competition and breeding. Both facilities provide on-call veterinary care and full-time staff.
Dr. Michael Lindinger, a former University of Guelph professor with more than 25 years of experience and one of Canada’s leading nutraceutical experts, will oversee the trials. Dr. Lindinger has offices in Ontario and Europe. He has led 130 peer-reviewed clinical trials, holds BSc and MSc degrees in comparative animal physiology and a PhD in medical sciences.
“With more than 15 million horses in North America and Europe, the equine healthcare market is a growing billion dollar industry. We recognize the opportunity to bring the transformative power of cannabis and cannabinoids we see working in humans and other animals to life for horses,” says Warren Byrne, President of CannaHorse. “Our team has deep knowledge of the equestrian world. We understand how horses are meant to perform and how to care for them. We are thrilled with Health Canada’s recent announcement about conducting consultations to allow cannabis health products to be sold outside the current cannabis framework and look forward to participating.”
“Cannabis is about to become the world’s most widely used medical substance for both people and animals,” comments Dr. Lindinger, PHD. “CannaHorse is taking a measured and scientific approach to their product development, something that is vital for any legitimate medical product.”
In addition to product development, CannaHorse offers consulting, product development partnerships, and testing and clinical trying coordination.
SOURCE CannaHorse
Cannabis
Sannabis, Inc. (OTC: USPS) Announces First Shipment of Cannabis Essential Oil from Colombia to U.S. to Fill First Order, as the DEA Re-Classifies Marijuana from Schedule I to Schedule III
Cannabis
Technological Advancements in Breathalyzers Drive Market Growth and Enhance Road Safety
Cannabis
Bay Area Social Equity Operator Launches the Purple Raina Balm Wand 1:1, an Inclusive Multipurpose Cannabis Topical
-
Innocan2 weeks ago
Innocan Pharma Initiates FDA Approval Process for Liposome Injection Therapy for Chronic Pain
-
Curaleaf2 weeks ago
Curaleaf Completes Acquisition of Northern Green Canada
-
Cannabis2 weeks ago
Cannabis Capsule Global Analysis Report 2024: Market to Reach $79.2 Billion in 2028 – Forecast to 2033 Featuring GW Pharmaceuticals, Trulieve Cannabis, Green Thumb Industries, Tilray, Columbia Care
-
Cannabis5 days ago
Technological Advancements in Breathalyzers Drive Market Growth and Enhance Road Safety
-
SCHWAZZE6 days ago
Schwazze Sets First Quarter 2024 Conference Call for May 15, 2024 at 5:00 p.m. ET
-
Cannabis5 days ago
Bay Area Social Equity Operator Launches the Purple Raina Balm Wand 1:1, an Inclusive Multipurpose Cannabis Topical
-
Humboldt5 days ago
Humboldt Seed Company partners with Apollo Green to bring California cannabis genetics to the global marketplace
-
Cannabis3 days ago
Sannabis, Inc. (OTC: USPS) Announces First Shipment of Cannabis Essential Oil from Colombia to U.S. to Fill First Order, as the DEA Re-Classifies Marijuana from Schedule I to Schedule III